At a glance
ClinicalIndex Comparison RecordN/ACompleted· 500 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Long-term Risks After Endoscopic Retrograde Cholangiopancreatography (ERCP) With Sphincterotomy.
In Brief
An observational study for Choledocholithiasis With Acute Cholangitis (Diagnosis) and Acute Pancreatitis Due to Gallstones. Completed, enrolled 500 participants.
Detailed Summary
Retrospective study to analyze benign complications and malignancy risks after ERCP with sphincterotomy. All patients who received a ERCP with sphincterotomy for a benign disease will be included. Post-ERCP hepato-biliary complications in the follow-up will be registered.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCholedocholithiasis With Acute Cholangitis (Diagnosis), Acute Pancreatitis Due to Gallstones
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJan 2017
Primary CompletionOct 2020
Study CompletionDec 2020
First PostedFeb 2021
TodayJul 2026
First PostedFeb 3, 2021
Enrollment StartJan 1, 2017
Primary CompletionOct 10, 2020
Study CompletionDec 20, 2020
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 5.4 years ago